Mancini Anthony sold RVMD
June 16, 2026 · Form 4 insider transaction
Mancini Anthony sold 4,615 shares of Revolution Medicines, Inc. at $156.12 per share, a transaction worth $720.5K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 2 days after the transaction.
Footnotes
Pursuant to an automatic sell-to-cover, the shares were sold following the vesting of the restricted stock units solely to cover applicable withholding taxes.; This transaction was executed in multiple trades at prices ranging from $156.1105 to $156.8250. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.; Includes 43,700 Restricted Stock Units.; Includes 190 shares acquired under the Issuer's Employee Stock Purchase Plan on May 31, 2026.